课题基金 / 基金详情

Elucidation of the transporters, and integration research of their molecular entities and activities for the drug transport in the brain and kidneys

Elucidation of the transporters, and integration research of their molecular entities and activities for the drug transport in the brain and kidneys
转运蛋白的阐明,及其分子实体和大脑和肾脏药物转运活性的整合研究
批准号:
23390034
负责人:
KUSUHARA Hiroyuki
金额:
$11.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

KUSUHARA Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
本研究阐明了作为H+/有机阳离子交换的MATEs介导多种药物、内源性代谢物(n -甲基烟酰胺)和荧光剂在小鼠尿排泄中的作用,并且对MATEs的抑制是西咪替丁和甲氧苄啶尿排泄中药物-药物相互作用的机制之一。NPT4介导多种阴离子药物如利尿剂在HEK293细胞中的扩散。发现MCT9在近端小管的基底外膜上表达。在尿排泄的药物中,OCT2只能识别亲水化合物作为底物。MCT9也作为有机阳离子转运体,表现出与OCT2不同的底物特异性。由于MCT9也在血脑屏障中表达,推测MCT9除参与肾脏外,还参与中枢神经系统的药物处置。
英文摘要
This study elucidated that MATEs which act as H+/organic cation exchanges mediate the urinary excretion of various drugs, endogenous metabolite (N-methylnicotinamide) and fluorescents in mouse, and that inhibition of MATEs is part of the mechanism underlying the drug-drug interactions in the urinary excretion with cimetidine and trimethoprim. NPT4 mediates facilitated diffusion of various anionic drugs such as diuretics in HEK293 cells. MCT9 is found to be expressed on the basolateral membrane of the proximal tubules. Among the drugs which undergo urinary excretion, OCT2 can recognize only hydrophilic compounds as substrate. MCT9 also acts as organic cation transporter showing substrate specificity distinct from OCT2. Since MCT9 is also expressed in the blood-brain barrier, it is speculated that MCT9 is involved in the disposition of drugs in the central nervous system in addition to the kidney.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2011
期刊: J Pharmacol Exp Ther
影响因子: 3.5
作者: [Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y]
通讯作者: Sugiyama Y
Drug-transport interactions : kinetic concepts and clinical studies to demonstrate relevance of in vitro mode predictions
药物转运相互作用:动力学概念和临床研究以证明体外模式预测的相关性
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Tsuchiya H, Matsunaga T, Aikawa K, Kamada N, Nakamura K, Ichikawa H, Sasaki K, Ohmori S, Y. Ogra, Otaka A, 楠原洋之]
通讯作者: 楠原洋之
Functional Characterization of organic cation transport in HEK293 cells
HEK293 细胞中有机阳离子运输的功能表征
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [小林和正, 他]
通讯作者: 他
カチオン性医薬品腎排泄過程における薬物間相互作用におけるMATEの関与
MATE参与阳离子药物肾脏排泄过程中的药物相互作用
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [R. Sato, B. Felder, M. Miki, K. Tsuzuki, H. Hayakawa, M. Izumi, 伊藤澄人]
通讯作者: 伊藤澄人
共 45 条
    Comprehensive analysis of endogenous compounds applicable to in vivo evaluation of drugs transporters
    • 批准号:
      24659071
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      KUSUHARA Hiroyuki
    • 依托单位:
    Development of quantitative evaluation method of the drug transport systems at the blood brain barrier which influences the CNS effect.
    • 批准号:
      20390046
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2008
    • 负责人:
      KUSUHARA Hiroyuki
    • 依托单位:
    Establishment of drugs for probing in vivo activity of xenobiotic transporters in humans
    • 批准号:
      18390046
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.44万
    • 财政年份:
      2006
    • 负责人:
      KUSUHARA Hiroyuki
    • 依托单位:
    海外基金